Regeneron Stock Sinks on Disappointing Product sales of Eylea Vaccine
Regeneron Pharmaceuticals inventory was tumbling just after the medication maker described reduced product sales of its Eylea vaccine than Wall ...
Read moreDetailsRegeneron Pharmaceuticals inventory was tumbling just after the medication maker described reduced product sales of its Eylea vaccine than Wall ...
Read moreDetailsAstraZeneca agreed to acquire U.S. biotech firm CinCor Pharma in a deal perhaps valued at $1.8 billion, the British pharmaceutical ...
Read moreDetailsWe've detected you are on Internet Explorer. For the best Barrons.com experience, please update to a modern browser. We've detected ...
Read moreDetailsAstraZeneca agreed to invest in U.S. biotech enterprise CinCor Pharma in a offer perhaps valued at $1.8 billion, the British ...
Read moreDetailsMy 2023 biotech outlook phone calls for ongoing momentum in identify alterations. I just have to have to determine out ...
Read moreDetailsMy 2023 biotech outlook calls for ongoing momentum in title variations. I just will need to determine out what the ...
Read moreDetailsAbbVie Inc. executives decreased their outlook for the quarter and yr in a filing with the Securities and Exchange Commission ...
Read moreDetailsFinancial institution of The us analysts upgraded BioNTech SE stock to acquire from maintain on Thursday, citing enjoyment about its ...
Read moreDetailsClovis Oncology Inc., maker of the ovarian and prostate most cancers drug Rubraca, filed for individual bankruptcy in excess of ...
Read moreDetailsAmgen attained a deal to invest in drug corporation Horizon Therapeutics for $116.50 a share in money. In a statement, ...
Read moreDetailsEmail Contact: souhaib@trendswide.com